Betta Pharmaceuticals Co., Ltd.

Betta Pharmaceuticals Co., Ltd. faced a challenging trading day on October 14, 2025, with a notable stock decline. Despite recent downturns, the company has achieved a strong annual return and maintains a significant market capitalization, alongside a high price-to-earnings ratio and a modest dividend yield.

Betta Pharmaceuticals Co., Ltd. saw a significant decline in its stock today, contrasting with the broader market's performance. Despite recent losses, the company has demonstrated strong long-term growth, with notable increases in stock value over the past year and three years, alongside key financial metrics reflecting its industry standing.

Betta Pharmaceuticals Co., Ltd. saw a decline in its stock today, contrasting with a gain in the China Shanghai Composite. Despite recent fluctuations, the company has achieved significant annual growth and maintains a strong market capitalization, price-to-earnings ratio, and return on equity, reflecting its long-term resilience.